Caption Management, LLC Catalent, Inc. Call Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $14.3 Million - $15.5 Million	255,000 New	255,000 $15.4 Million
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $1.06 Million - $1.5 Million	-25,000 Reduced 50.0%	25,000 $1.41 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $2.64 Million - $3.82 Million	-82,000 Reduced 62.12%	50,000 $2.25 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $9.03 Million - $10.3 Million	-204,200 Reduced 60.74%	132,000 $6.01 Million
Q2 2023 Aug 14, 2023	BUY	$31.86 - $67.26 $10.1 Million - $21.3 Million	316,700 Added 1624.1%	336,200 $14.6 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $3.2 Million - $5.24 Million	-70,500 Reduced 78.33%	19,500 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $3.73 Million - $7.29 Million	90,000 New	90,000 $4.05 Million
Q1 2019 May 14, 2019	BUY	$29.84 - $43.92 $2.98 Million - $4.39 Million	100,000 New	100,000 $4.06 Million

510

150M

510K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.